Ortho Innovators: Advance Your Technology, at Any Phase in Its Pathway, by Connecting with GCMI at ORS 2023

If you’re attending ORS 2023 and have a new orthopedic technology in development, including preclinical work that may be on your product development horizon, you have a wonderful chance to connect with our Director of Scientific Affairs Evan Goldberg onsite.   GCMI is the U.S. proving ground for global medical innovation. Our mission is to…

Aligned Career Opportunity: Project Manager to Advance Research and Education in Neuroscience.

Our colleague Chris Rozell, Professor and Julian T. Hightower Chair,Technical Interest Groups: Bioengineering, Digital Signal Processing at Georgia Tech asked us to share the following career opportunity advancing research and education in neuroscience. We hope this initiative and position will have the opportunity to work closely with GCMI in the future. From Chris: Georgia Tech…

Come work with our industry leading medtech innovation design and development team – Seeking a senior research engineer to join the GCMI team

GCMI, a non-profit affiliate of the Georgia Institute of Technology, is actively recruiting for a research engineer to lead multiple new medtech product development projects.   The medical device design services and product development team at GCMI facilitates medical product development through all phases – from initial concept generation through transfer to production manufacturing. We…

Interdisciplinary Innovation in Action – 2022 Fall Capstone Team Wristy Business Tackles a Standard of Care Treatment Suffering from a 40-70% Failure Rate

The human wrist is a complex arrangement of short, small bones, component joints and ligaments. Especially among young, active people, it is subject to approximately 20,000 instances of scapholunate ligament (SLL) tears, mostly the result of an intense impact to the hand.   Left untreated, SLL tears can degrade quickly, leading to the untreatable scapholunate…

Can Preclinical Studies Actually Be Agile?

Quick Insights Aligned in Acceleration: Indeed, the Most Expensive Preclinical Study is the One You Have to Do Twice As mentioned in a post last month, our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways, all of which center around actionable insights generation and insights management. …

Beware the Unfamiliar Approach: Preclinical Implications for Novel Cell & Gene Therapies

Roughly one decade ago, scientists made significant improvements in viral vectors’ ability to deliver genetic therapeutics. Those therapies use genetic material like DNA to manipulate a patients’ own cells. Cellular (cell) therapies transfer cells into the patient whether they are the patients’ own cells or cells derived from another location or donor cells.    Because…

Who brings what to the table? Artivion’s Deepal Stevenson, M.S. shares her insights on the client / CRO relationship for effective, efficient preclinical studies and reports.

Life science companies of all shapes and sizes rely on preclinical contract research organizations (CROs) to generate the data and reports required to bring their innovations to market.   To do this effectively, and in a capital efficient manner, each entity needs to understand what they need from the other, when they need it, why…

Q&A with an Industry Leader – What’s One Area Especially Ripe for Acceleration in Preclinical Work? Hint: It’s Not the OR.

As we shared recently, our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways. Their platform improves life science teams’ engagement in asynchronous applications like advisory boards, helps teams find the right KOLs anywhere on the globe and helps teams make the most out of medical congresses…

Aligned in Acceleration: An Introduction to Our Colleagues at Within3, Their Insights Management Platform and Its Potential Implications for Preclinical Testing

Our colleagues at Within3 are using technology to accelerate pharma and medtech innovation in some very interesting ways. Their platform improves life science teams’ engagement with key opinion leaders in asynchronous applications like advisory boards, helps teams find the right KOLs anywhere on the globe and helps teams make the most out of medical congresses…

Preclinical Implications for 3D Printed and Bioresorbable Medical Technologies

The phrase “personalized medicine” has been thrown about by so many for so long in healthcare as to defy definition: or require post graduate work in any one of dozens of specific clinical or technological fields.   For the sake of brevity, 3D printing and bioresorbable material technologies are actively realizing personalized medicine in the…